首页 › 急性淋巴细胞白血病 › 犹他州 › Salt Lake City
Salt Lake City UT 急性淋巴细胞白血病临床试验
10项针对 急性淋巴细胞白血病的研究正在 Salt Lake City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
招募中1 期
- Primary Children's Hospital, Salt Lake City
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
招募中
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
招募中1 期
- Huntsman Cancer Institute, Salt Lake City
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Primary Children's Hospital, Salt Lake City
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
招募中2 期
- Primary Children's Hospital, Salt Lake City
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- University of Utah, Salt Lake City
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
招募中1/2 期
- University of Utah Huntsman Cancer Institute, Salt Lake City
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
招募中1 期
- University of Utah, Salt Lake City
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
招募中1/2 期
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
招募中1 期
- Primary Children's Hospital, Salt Lake City
其他城市的 急性淋巴细胞白血病试验
- Houston, TX28 项研究
- New York City, NY23 项研究
- Baldwin Park, CA21 项研究
- Seattle, WA21 项研究
- Chicago, IL20 项研究
- Atlanta, GA19 项研究
- Memphis, TN16 项研究
- Washington, DC16 项研究
- Philadelphia, PA16 项研究
- Boston, MA15 项研究
- Los Angeles, CA14 项研究
- Mountain View, CA13 项研究
Salt Lake City的其他研究
- 非小细胞肺癌31 项研究
- 癌症（所有类型）27 项研究
- 乳腺癌27 项研究
- 结直肠癌22 项研究
- 肺癌21 项研究
- 黑色素瘤21 项研究
- 多发性骨髓瘤21 项研究
- 转移性癌症20 项研究
- 卵巢癌19 项研究
- 肥胖症18 项研究
- 急性髓系白血病17 项研究
- 心力衰竭17 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。